This innovative CME symposium will look at the complex interrelationships of cardiovascular (CV) disease risk as a combination of non-HDL-C, including triglyceride-rich lipoproteins, inflammatory components, glucose-based pathways, and other mechanisms associated with CV disease and its dreaded outcomes.
Enroll in this meeting
Enrollment Fee: FreeFree
6:00 pm–6:30 pm
Registration & Buffet Dinner
6:30 pm–6:40 pm
6:40 pm–7:00 pm
REDUCE-IT and Other Omega-3 Trials
7:00 pm–7:20 pm
Biologic Basis for EPA Modulation in Reducing ASCVD Events Seen in REDUCE-IT
7:20 pm–7:40 pm
A New Era in CVD Risk Reduction with Glucose- and Lipid-lowering Agents
7:40 pm–8:00 pm
Clinician Live Discussion
8:00 pm–8:10 pm
Challenging Cases for Discussion
8:10 pm-8:15 pm
After completing this activity, participants should be better able to:
- Discuss the results and importance of REDUCE-IT and other recent cardiovascular outcomes trials that reduce ASCVD events beyond statin therapy in patients with diabetes
- Describe the potential biologic basis for the reductions in ASCVD events observed in REDUCE-IT
- Apply evidence-based trial data and guidelines to lifestyle and therapeutic approaches for managing patients with diabetes who have ASCVD or are at high risk of ASCVD events
Endocrinologists, lipidologists, internists, NPs/PAs, diabetes educators, nurses, and other healthcare providers who care for patients with type 2 diabetes, and patients with dyslipidemia.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Omnia-Prova Education Collaborative (TOPEC) and Medtelligence. TOPEC is accredited by the ACCME to provide continuing medical education for physicians.
The Omnia-Prova Education Collaborative, Inc. designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The information provided at this activity is for continuing education purposes only and is not meant to substitute the independent medical judgment of a health care provider relative to diagnostic and treatment options of a specific patient’s medical condition.